Showing results (101-110 of 231) with videos related to
Sort By:
Pageof 24
Radiology|March 1, 2022
A Novel Benchmarking Approach to Assess the Agreement among Radiomic ToolsAndrea Bettinelli, Francesca Marturano, Michele Avanzo, et al.Medical Physics|October 27, 2016
Technical Note: Multicenter study of TrueBeam FFF beams with a new stereotactic diode: Can a common small field signal ratio curve be defined?Elisabetta Cagni, Serenella Russo, Giacomo Reggiori, et al.Journal of Experimental & Clinical Cancer Research : CR|January 5, 2019
Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cellsRossella Loria, Claudia Giliberti, Angelico Bedini, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 6, 2021
Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot StudyMatteo Serenari, Alberta Cappelli, Alessandro Cucchetti, et al.Frontiers in Oncology|December 6, 2021
Clinical Studies on Ultrafractionated Chemoradiation: A Systematic ReviewErica Scirocco, Francesco Cellini, Alice Zamagni, et al.Current Oncology (Toronto, Ont.)|April 21, 2022
Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic ReviewMilly Buwenge, Alessandra Arcelli, Francesco Cellini, et al.Cancers|June 10, 2022
Memantine in the Prevention of Radiation-Induced Brain Damage: A Narrative ReviewClaudia Scampoli, Silvia Cammelli, Erika Galietta, et al.Journal of Experimental & Clinical Cancer Research : CR|September 7, 2021
The role of dosimetry and biological effects in metastatic castration-resistant prostate cancer (mCRPC) patients treated with <sup>223</sup>Ra: first in human studyRosa Sciuto, Sandra Rea, Sara Ungania, et al.Anti-Cancer Drugs|October 21, 2016
Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetateSilvana Giacinti, Paolo Carlini, Michela Roberto, et al.Medical Physics|March 15, 2023
A novel tool for predicting the dose distribution of non-sealed <sup>188</sup> Re (Rhenium) resin in non-melanoma skin cancers (NMSC) patientsFederico Zagni, Sara Vichi, Giulia Paolani, et al.Pageof 24